Sponsors (24)
The bill preserves and strengthens state authority to require and enforce expanded abortion disclosures, but does so at the cost of adding potential misinformation, higher provider compliance costs and legal risk, and uneven access across states.
State governments retain authority to impose stronger penalties for failure to comply with abortion disclosure rules, which may improve local enforcement of disclosure requirements.
State governments keep the ability to require fuller abortion disclosures, preserving the option for states to mandate more comprehensive information to patients in those states.
Pregnant people considering medication abortion would receive additional information about a proposed 'abortion pill reversal' option, increasing the set of topics discussed during counseling.
Clinics and healthcare providers would face increased administrative and compliance costs and greater legal risk (including potential penalties), which could raise operating costs and shrink availability of medication abortion services.
Pregnant people could be given misleading or unsupported medical information about an unproven 'abortion pill reversal' method, risking harm from delayed or inappropriate care.
Allowing varied state disclosure and penalty rules risks creating a patchwork that confuses patients and providers across states, producing uneven access and legal uncertainty for care.
Based on analysis of 4 sections of legislative text.
Adds an "abortion pill reversal informed consent" provision to federal public health law (operative text not provided) and preserves states' ability to require stricter disclosures or penalties.
Creates a new federal "abortion pill reversal informed consent" provision in the Public Health Service Act (text not included) and declares an official short title. It preserves State authority to maintain or adopt disclosure or penalty rules that are more stringent than the federal provision, and includes a severability clause so remaining parts survive if one part is invalidated. Because the substantive text of the new provision is not provided, specific requirements, definitions, agencies, timelines, or funding cannot be determined from the submission.
Official title: To ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind, and for other purposes.
Introduced September 18, 2025 by August Pfluger · Last progress September 18, 2025